KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

LifeMD (LFMD) Operating Expenses (2016 - 2025)

LifeMD's Operating Expenses history spans 14 years, with the latest figure at $9.1 million for Q4 2025.

  • For Q4 2025, Operating Expenses rose 94.92% year-over-year to $9.1 million; the TTM value through Dec 2025 reached $174.0 million, up 12.58%, while the annual FY2025 figure was $174.0 million, 13.15% up from the prior year.
  • Operating Expenses reached $9.1 million in Q4 2025 per LFMD's latest filing, down from $54.7 million in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $55.7 million in Q2 2025 to a low of $4.7 million in Q4 2024.
  • Average Operating Expenses over 5 years is $37.5 million, with a median of $36.6 million recorded in 2022.
  • Peak YoY movement for Operating Expenses: soared 471.52% in 2021, then crashed 88.83% in 2024.
  • A 5-year view of Operating Expenses shows it stood at $35.5 million in 2021, then fell by 3.07% to $34.4 million in 2022, then increased by 21.07% to $41.7 million in 2023, then plummeted by 88.83% to $4.7 million in 2024, then surged by 94.92% to $9.1 million in 2025.
  • Per Business Quant, the three most recent readings for LFMD's Operating Expenses are $9.1 million (Q4 2025), $54.7 million (Q3 2025), and $55.7 million (Q2 2025).